CIK 0001671927 · Large accelerated filer
Immunocore Holdings plc
Sign in to watch- Ticker
- IMCR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 01235 5430281
- Business address
- 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom, OX14 4RY
- Former names
- Immunocore Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Grant or award · Employee Share Option (Right to Buy) | +405,824 | 405,824 | ||
| 2025-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Share Units | +95,270 | 95,270 | ||
| 2025-01-01 | Coy Travis Alan Chief Financial Officer | Grant or award · Employee Share Option (Right to Buy) | +274,033 | 274,033 | ||
| 2024-05-28 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +12,925 | 12,925 | ||
| 2024-05-28 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +12,925 | 12,925 | ||
| 2024-05-23 | Kaul Siddharth Director | Grant or award · Share Option (Right to Buy) | +14,534 | 14,534 | ||
| 2024-05-23 | Ratcliffe Peter John Director | Grant or award · Share Option (Right to Buy) | +14,534 | 14,534 | ||
| 2024-05-23 | Peterson Kristine Director | Grant or award · Share Option (Right to Buy) | +14,534 | 14,534 | ||
| 2024-05-23 | Herbst Roy Steven Director | Grant or award · Share Option (Right to Buy) | +14,534 | 14,534 | ||
| 2024-05-23 | Bell John Irving Director | Grant or award · Share Option (Right to Buy) | +14,534 | 14,534 | ||
| 2024-04-01 | St Leger Tina Amber CHIEF HR OFFICER | Option exercise 10b5-1 | +4,375 | $29.87 | $131K | 4,375 |
| 2024-04-01 | St Leger Tina Amber CHIEF HR OFFICER | Sale 10b5-1 | −4,375 | $64.06 | $280K | 0 |
| 2024-04-01 | St Leger Tina Amber CHIEF HR OFFICER | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −4,375 | 35,000 | ||
| 2024-02-28 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +36,509 | $17.46 | $637K | 36,509 |
| 2024-02-28 | Berman David M HEAD OF R&D | Sale 10b5-1 | −16,900 | $67.61 | $1.1M | 19,609 |
| 2024-02-28 | Berman David M HEAD OF R&D | Sale 10b5-1 | −7,472 | $68.84 | $514K | 12,137 |
| 2024-02-28 | Berman David M HEAD OF R&D | Sale 10b5-1 | −10,937 | $69.73 | $763K | 1,200 |
| 2024-02-28 | Berman David M HEAD OF R&D | Sale 10b5-1 | −1,200 | $70.45 | $85K | 0 |
| 2024-02-28 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −36,509 | 271,790 | ||
| 2024-02-27 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +54,938 | $17.46 | $959K | 54,938 |
Page 5 of 6 · 118 trades